- Home
- AMLX vs SSYS Comparison
AMLX vs SSYS Comparison
Compare AMLX & SSYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMLX
- SSYS
- Stock Information
- Founded
- AMLX 2014
- SSYS 1989
- Country
- AMLX United States
- SSYS United States
- Employees
- AMLX N/A
- SSYS N/A
- Industry
- AMLX Biotechnology: Pharmaceutical Preparations
- SSYS Computer peripheral equipment
- Sector
- AMLX Health Care
- SSYS Technology
- Exchange
- AMLX Nasdaq
- SSYS Nasdaq
- Market Cap
- AMLX 749.9M
- SSYS 857.2M
- IPO Year
- AMLX 2022
- SSYS 1994
- Fundamental
- Price
- AMLX $8.00
- SSYS $9.40
- Analyst Decision
- AMLX Strong Buy
- SSYS Strong Buy
- Analyst Count
- AMLX 7
- SSYS 4
- Target Price
- AMLX $12.00
- SSYS $12.50
- AVG Volume (30 Days)
- AMLX 1.0M
- SSYS 690.7K
- Earning Date
- AMLX 08-07-2025
- SSYS 08-13-2025
- Dividend Yield
- AMLX N/A
- SSYS N/A
- EPS Growth
- AMLX N/A
- SSYS N/A
- EPS
- AMLX N/A
- SSYS N/A
- Revenue
- AMLX N/A
- SSYS $564,499,000.00
- Revenue This Year
- AMLX N/A
- SSYS $2.01
- Revenue Next Year
- AMLX N/A
- SSYS $4.01
- P/E Ratio
- AMLX N/A
- SSYS N/A
- Revenue Growth
- AMLX N/A
- SSYS N/A
- 52 Week Low
- AMLX $2.05
- SSYS $6.05
- 52 Week High
- AMLX $8.72
- SSYS $12.88
- Technical
- Relative Strength Index (RSI)
- AMLX 53.91
- SSYS 34.89
- Support Level
- AMLX $7.48
- SSYS $9.04
- Resistance Level
- AMLX $8.49
- SSYS $11.57
- Average True Range (ATR)
- AMLX 0.40
- SSYS 0.41
- MACD
- AMLX -0.06
- SSYS -0.17
- Stochastic Oscillator
- AMLX 51.49
- SSYS 14.23
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.
About SSYS Stratasys Ltd. (Israel)
Stratasys Ltd is a polymer-based 3D printing solution, which provides a product life cycle, with multiple technologies and complete solutions for superior application fit, across industrial, healthcare, and consumer fields. It focuses, in particular, on polymer 3D printing solutions that address the fastest-growing manufacturing solutions viewed as the potential growth opportunity in the 3D printing industry. Its printers include FDM, PolyJet, Stereolithography, P3, and SAF. Its software is GrabCAD Software, Connectivity, Digital Anatomy Creator, and OpenAM Software. It generates revenue through 3D printing systems, related services, and consumables and by providing additive manufacturing solutions.